What laboratory abnormalities are typical in Cushing’s disease caused by an ACTH (adrenocorticotropic hormone)‑secreting pituitary adenoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Abnormalities in Cushing's Disease

In Cushing's disease caused by an ACTH-secreting pituitary adenoma, expect elevated or normal-high ACTH levels (>5 pg/mL, often >29 pg/mL), elevated 24-hour urinary free cortisol (>100 μg/24h), elevated late-night salivary cortisol (>3.6 nmol/L), loss of normal circadian rhythm with elevated midnight cortisol (>50 nmol/L), and failure to suppress cortisol below 1.8 μg/dL on the 1-mg overnight dexamethasone suppression test. 1, 2, 3

Core Biochemical Features

ACTH Levels

  • Morning plasma ACTH >5 pg/mL (>1.1 pmol/L) is detectable in all patients with Cushing's disease and indicates ACTH-dependent hypercortisolism. 1, 3
  • ACTH >29 pg/mL (>6.4 pmol/L) provides 70% sensitivity and 100% specificity for diagnosing pituitary Cushing's disease specifically (versus ectopic ACTH). 1, 3
  • ACTH should be measured in the morning (08:00-09:00h) when levels are physiologically highest, as this timing corresponds to established diagnostic cutoffs. 1
  • In contrast, ACTH-independent adrenal causes show suppressed or undetectable ACTH (<5 pg/mL). 1, 3

Cortisol Abnormalities

Loss of Circadian Rhythm:

  • Midnight serum cortisol >50 nmol/L (>1.8 μg/dL) or late-night salivary cortisol >3.6 nmol/L indicates loss of the normal cortisol nadir—a hallmark of Cushing's disease. 1, 2
  • Late-night salivary cortisol has 92-100% sensitivity and 93-100% specificity; obtain 2-3 samples on different nights to account for cyclic disease. 2
  • A single midnight serum cortisol >207 nmol/L (>7.5 μg/dL) provides 96% sensitivity and 100% specificity. 2

24-Hour Urinary Free Cortisol:

  • Values >100 μg/24h (>1.6 μmol/24h) on multiple collections (at least 2-3) are diagnostic in symptomatic patients. 2, 3
  • UFC has >90% sensitivity but shows up to 50% random variability between collections, necessitating multiple measurements. 2
  • Ensure complete 24-hour collection by measuring total volume and creatinine excretion; incomplete collections are the most common cause of false results. 2

Dexamethasone Suppression Test:

  • Cortisol ≥1.8 μg/dL (≥50 nmol/L) at 08:00h after 1 mg dexamethasone given at 23:00-24:00h indicates abnormal suppression. 2, 3
  • Cortisol >5 μg/dL (>138 nmol/L) post-dexamethasone indicates overt Cushing's syndrome. 2
  • Measure dexamethasone levels concomitantly to exclude false-positive results from abnormal drug metabolism or malabsorption. 1, 2

Additional Laboratory Findings

Metabolic Abnormalities

  • Hypokalemia may be present but is more pronounced in ectopic ACTH syndrome; when severe, it suggests extremely high cortisol levels overwhelming 11β-HSD2 and producing mineralocorticoid effects. 1
  • Hyperglycemia and impaired glucose tolerance are common due to cortisol's anti-insulin effects. 4
  • Hyponatremia is less common in Cushing's disease but may occur. 2

Pattern Recognition

  • The coefficient of variation of cortisol levels is typically subnormal in Cushing's disease, reflecting altered pulsatility. 5
  • Some patients retain a circadian rhythm pattern but with elevated baseline levels throughout the 24-hour period. 5
  • Cushing's disease often shows a combination of episodic cortisol release (under residual CRH control) and continuous secretion from autonomous ACTH. 5

Critical Diagnostic Pitfalls

False Elevations to Exclude

  • Oral estrogen/contraceptives increase cortisol-binding globulin (CBG), falsely elevating total cortisol while free cortisol remains normal—always inquire about these before pursuing extensive workup. 2
  • Pregnancy similarly increases CBG and total cortisol. 2
  • CYP3A4 inducers (phenytoin, rifampin, carbamazepine) accelerate dexamethasone metabolism, causing false-positive suppression tests. 2
  • Exogenous glucocorticoids (oral, inhaled fluticasone, topical, intra-articular/epidural injections) must be excluded before any testing, as they suppress endogenous cortisol and invalidate results. 2

Pseudo-Cushing's States

  • Severe obesity, depression, alcoholism, and polycystic ovary syndrome can activate the HPA axis and cause mildly elevated cortisol that mimics true hypercortisolism. 2, 3
  • These conditions typically show blunted ACTH responses to CRH stimulation, unlike true Cushing's disease. 1

Cyclic Cushing's Disease

  • Patients may have weeks to months of normal cortisol secretion interspersed with hypercortisolism, producing inconsistent test results depending on sampling timing. 1, 2
  • This necessitates repeated testing (2-3 measurements of each modality) and extended monitoring during symptomatic periods. 2

Diagnostic Algorithm Summary

  1. Screen with 2-3 measurements of at least two tests: 24-hour UFC, late-night salivary cortisol, and/or 1-mg overnight dexamethasone suppression test. 2, 3
  2. Measure morning (09:00h) plasma ACTH once hypercortisolism is confirmed to determine ACTH-dependency. 1, 3
  3. ACTH >5 pg/mL confirms ACTH-dependent disease; proceed to pituitary MRI. 1, 3
  4. If MRI shows adenoma ≥10 mm, presume Cushing's disease and proceed to surgery. 1
  5. If MRI shows lesion 6-9 mm, perform CRH or desmopressin stimulation test (cortisol rise >38 nmol/L at 15 minutes supports pituitary source). 1
  6. If MRI shows no adenoma or lesion <6 mm, perform bilateral inferior petrosal sinus sampling (BIPSS) with central-to-peripheral ACTH ratio ≥2:1 baseline or ≥3:1 post-stimulation confirming pituitary source. 1, 3

References

Guideline

Cushing's Syndrome Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cortisol Levels and Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosing ACTH-Dependent Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the stepwise diagnostic approach for confirming Cushing disease (ACTH‑secreting pituitary adenoma) in an adult presenting with signs of hypercortisolism such as central obesity, moon face, dorsocervical fat pad, skin thinning, easy bruising, violaceous striae, hypertension, glucose intolerance, or osteoporosis?
What are the clinical features of Cushing's syndrome?
What is the most likely cause of Cushing's syndrome in a patient with elevated Adrenocorticotropic hormone (ACTH) and cortisol levels, who developed symptoms such as facial hair, striae, and obesity over 3-4 months?
What is the latest protocol for the workup of adrenal adenoma Cushing's (Cushing's syndrome)?
What are the diagnostic criteria and current treatment guidelines for Cushing's disease in adults, particularly females, presenting with symptoms such as weight gain, hypertension, diabetes, and osteoporosis?
In an adult on chronic dialysis with hemoglobin 11 g/dL, low serum iron, low total iron‑binding capacity, and high ferritin, what is the appropriate management of anemia?
Why does Cushing's disease cause atrial fibrillation that is refractory to cardioversion?
Can the adult National Early Warning Score 2 be used in pediatric patients?
What is the Pediatric Early Warning Score (PEWS), how is it calculated from vital signs, and what monitoring or escalation actions correspond to score ranges of 0‑2, 3‑4, and ≥5?
What laboratory tests should be ordered to reassess iron deficiency anemia?
In a patient with primary open‑angle glaucoma who has confirmed visual‑field progression despite current treatment, what is the next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.